Trisha Richards, PA
Medical · Highland, ILNPI 1760636088
Payments from drug & device makers
Across 237 payments — averaging $14.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$835
- Novo Nordisk$707
- Lilly USA, LLC$504
- AstraZeneca$504
- Johnson & Johnson$101
- Abbott$85
- plus $602 from 17 others
What the payments were for
- Food & beverage$3,29299%
- Education$461%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $835 |
| Novo Nordisk | 68 | $707 |
| Lilly USA, LLC | 28 | $504 |
| AstraZeneca | 24 | $504 |
| Johnson & Johnson | 7 | $101 |
| Abbott | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Novartis | 4 | $72 |
| Amarin Pharma, Inc. | 3 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Lundbeck LLC | 1 | $39 |
| GSK | 2 | $38 |
| Pfizer | 2 | $36 |
| Boehringer Ingelheim | 2 | $36 |
| Exact Sciences | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Amgen | 1 | $15 |
| Apria Healthcare LLC | 1 | $12 |
How this compares
$3,338 in reported general payments places this provider in the 80th percentile of 449 medical providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 87 | $114,978 |
| FarxigaDapagliflozin Propanediol | 67 | $76,545 |
| EliquisApixaban | 44 | $49,038 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $28,183 |
| JanuviaSitagliptin Phosphate | 15 | $23,132 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $21,411 |
| JardianceEmpagliflozin | 18 | $17,804 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $15,590 |
| XareltoRivaroxaban | 11 | $7,088 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $5,421 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $5,158 |
| Atorvastatin Calcium | 231 | $2,764 |
| Nebivolol Hcl | 33 | $2,574 |
| Varenicline Tartrate | 19 | $2,513 |
| Levothyroxine Sodium | 223 | $2,109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $707 | $114,97887 claims |
| AstraZenecaFarxiga | $504 | $76,54567 claims |
| PfizerEliquis | $36 | $49,03844 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $38 | $37,00157 claims |
| MerckJanuvia, Janumet Xr | $15 | $28,55326 claims |
| Boehringer IngelheimJardiance | $36 | $17,80418 claims |
| Johnson & JohnsonXarelto | $101 | $7,08811 claims |
| AbbVieSynthroid | $835 | $1,13819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 449 medical providers in Illinois.
Other medical in Highland
- Andrea TurekChicago$145K
- Priya BediElmhurst$56K
- Jennifer GarsonChicago$32K
- Bernice JohnsonPalos Heights$32K
- William KvasnickaChicago$19K
- Katie SpringerLake Forest$17K
- Matthew BrunoMorris$17K
- Kelly BrawleyBarrington$14K
- Megan GriggsSpringfield$13K
- Marianne RaoAlgonquin$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.